Healthtech Solutions Inc. (HLTT) Adopts New Portfolio Model with Varian Bio Acquisition
McKinsey & Company notes that portfolio model is growing in popularity amongst companies and investors HLTT recently acquired precision oncology company Varian Biopharma Report shows that more than $5.5 billion in capital has been raised in past six years by companies with biotech portfolio models An emerging trend in biotechnology involves abandoning a single shot on goal approach in favor of a broader strategy with different portfolio companies under one umbrella. The old incubator approach with a new flare, the trend involves a portfolio manager utilizing a variety of skillsets to assemble a group of subsidiaries, each committed to a…







